EUCAST ciprofloxacin area of technical uncertainty in Escherichia coli and Klebsiella pneumoniae using BD Phoenix™ and VITEK® 2 automated susceptibility systems
Files
Publication date
2024-10-01
Authors
Harryvan, T. J.
Schaftenaar, E.
Franssens, Bas T.
Melles, D. C.
Rentenaar, R. J.
Editors
Advisors
Supervisors
Document Type
Article
Metadata
Show full item recordCollections
License
cc_by_nc
Abstract
Keywords
Pharmacology, Microbiology (medical), Pharmacology (medical), Infectious Diseases
Citation
Harryvan, T J, Schaftenaar, E, Franssens, B T, Melles, D C & Rentenaar, R J 2024, 'EUCAST ciprofloxacin area of technical uncertainty in Escherichia coli and Klebsiella pneumoniae using BD Phoenix™ and VITEK® 2 automated susceptibility systems', The Journal of antimicrobial chemotherapy, vol. 79, no. 10, pp. 2718-2719. https://doi.org/10.1093/jac/dkae245